journal
https://read.qxmd.com/read/38530676/extraocular-muscle-inflammation-and-strabismus-in-a-patient-with-zoster-ophthalmicus
#1
JOURNAL ARTICLE
Jonathan Thomas, David Leake, Mary Kelly Green
No abstract text is available yet for this article.
March 26, 2024: Ophthalmology
https://read.qxmd.com/read/38520444/ocular-surface-fibroma-a-rare-benign-tumor-of-the-conjunctiva
#2
JOURNAL ARTICLE
Thomas A Weppelmann, Curtis E Margo, Edgar M Espana
No abstract text is available yet for this article.
March 23, 2024: Ophthalmology
https://read.qxmd.com/read/38520442/vascular-aneurysm-in-persistent-pupillary-membrane
#3
JOURNAL ARTICLE
Yuta Nariya, Takashi Ono, Takashi Miyai
No abstract text is available yet for this article.
March 23, 2024: Ophthalmology
https://read.qxmd.com/read/38522600/incident-non-infectious-uveitis-risk-after-immune-checkpoint-inhibitor-treatment
#4
JOURNAL ARTICLE
Myung Soo Chang, Seung Won Lee, Sunyeup Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Yong Joon Kim
Our findings suggest that, while incident uveitis is rare in patients with cancer treated with anti-PD-1/PD-L1 inhibitors, there is an increased risk in those with skin melanoma, warranting vigilant monitoring for uveitis in this subgroup.
March 22, 2024: Ophthalmology
https://read.qxmd.com/read/38520443/conjunctival-squamous-cell-carcinoma-presenting-after-chemical-burn-injury
#5
JOURNAL ARTICLE
Wenyu Deng, Codrin Iacob, Roman Shinder
No abstract text is available yet for this article.
March 22, 2024: Ophthalmology
https://read.qxmd.com/read/38506774/eyelid-metastatic-renal-clear-cell-carcinoma-mimics-sebaceous-carcinoma
#6
JOURNAL ARTICLE
Mingpeng Xu, Chuandi Zhou, Jiang Li
No abstract text is available yet for this article.
March 18, 2024: Ophthalmology
https://read.qxmd.com/read/38506773/triamcinolone-accumulation-associated-with-visual-loss
#7
JOURNAL ARTICLE
Pedro Carreira, Diogo Cabral
No abstract text is available yet for this article.
March 18, 2024: Ophthalmology
https://read.qxmd.com/read/38494130/five-year-clinical-trial-of-low-concentration-atropine-for-myopia-progression-lamp-study-phase-4-report
#8
JOURNAL ARTICLE
Xiu Juan Zhang, Yuzhou Zhang, Benjamin H K Yip, Ka Wai Kam, Fangyao Tang, Xiangtian Ling, Mandy P H Ng, Alvin L Young, Pei-Chang Wu, Clement C Tham, Li Jia Chen, Chi Pui Pang, Jason C Yam
PURPOSE: To evaluate (1) the long-term efficacy of low-concentration atropine over 5 years, (2) the proportion of children requiring retreatment and associated factors (3) the efficacy of pro re nata (PRN) retreatment using 0.05% atropine from year 3 to 5. DESIGN: A randomized, double-masked extended trial. METHODS: Children aged 4-12 years originally from the Low-Concentration Atropine for Myopia Progression study were followed up for 5 years...
March 15, 2024: Ophthalmology
https://read.qxmd.com/read/38492865/an-evaluation-of-the-efficacy-and-safety-of-timolol-maleate-0-5-microdrops-administered-with-the-nanodropper%C3%A2
#9
JOURNAL ARTICLE
Jennifer S Steger, Indira Durai, Annamalai Odayappan, Ramalakshmi Raman, Talla Sruthi, Allisa J Song, George Puthuran, Rengaraj Venkatesh, Elizabeth Colantuoni, Alan L Robin
OBJECTIVE OR PURPOSE: Examine if 12.5 μL timolol maleate 0.5% microdrops dispensed with the Nanodropper® Adaptor provide non-inferior intraocular pressure (IOP) reduction compared to conventional, 28 μL drops in open-angle glaucoma (OAG) and ocular hypertension (OHT) patients. DESIGN: Prospective, non-inferiority, parallel, multicenter, single-masked, active-controlled, randomized trial. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Treatment-naïve subjects that were recently diagnosed with OAG/OHT at the Aravind Eye Care System...
March 14, 2024: Ophthalmology
https://read.qxmd.com/read/38492864/dexamethasone-intracanalicular-insert-for-clinically-significant-aqueous-deficient-dry-eye-a-randomized-controlled-trial
#10
JOURNAL ARTICLE
Michael Lin, Lee Guo, Ian J Saldanha, Shanna VanCourt, Julia Zeng, Sezen Karakus, Michelle Hessen, Gavin Li, Esen K Akpek
PURPOSE: To evaluate a commercially available dexamethasone intracanalicular insert to treat dry eye. DESIGN: Single-center, double-masked, randomized controlled trial. PARTICIPANTS: Patients with clinically significant aqueous-deficient dry eye [combined ocular surface staining score ≥3 (0-12), corneal fluorescein staining ≥2 (0-6), and Schirmer's wetting <10 mm at 5 minutes in both eyes] with symptoms (dryness, eye discomfort, or visual fatigue, ≥30 [0-100]) despite treatment with at least one prescription drop and deemed candidate for topical steroid...
March 14, 2024: Ophthalmology
https://read.qxmd.com/read/38490274/association-between-glucagon-like-peptide-1-receptor-agonists-and-the-risk-of-glaucoma-in-individuals-with-type-2-diabetes
#11
JOURNAL ARTICLE
Siar Niazi, Filip Gnesin, Anna-Sophie Thein, Jens R Andreasen, Anna Horwitz, Zaynab A Mouhammad, Baker N Jawad, Zia Niazi, Nelsan Pourhadi, Bochra Zareini, Amani Meaidi, Christian Torp-Pedersen, Miriam Kolko
PURPOSE: To examine the association between Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) use and the development of glaucoma in individuals with type 2 diabetes. DESIGN: Nationwide, nested case-control study. PARTICIPANTS: From a nationwide cohort of 264708 individuals, we identified 1,737 incident glaucoma cases and matched them to 8685 glaucoma-free controls, all aged above 21 years old and treated with metformin and a second-line antihyperglycemic drug formulation, with no history of glaucoma, eye trauma or eye surgery...
March 8, 2024: Ophthalmology
https://read.qxmd.com/read/38456856/medial-canthal-collision-tumor-with-seborrheic-keratosis-hiding-underlying-basal-cell-carcinoma
#12
JOURNAL ARTICLE
Wenyu Deng, Jodi Sassoon, Roman Shinder
No abstract text is available yet for this article.
March 7, 2024: Ophthalmology
https://read.qxmd.com/read/38452874/ocular-mucous-membrane-pemphigoid-the-effect-of-risk-factors-at-presentation-on-treatment-outcomes
#13
JOURNAL ARTICLE
Raul E Ruiz-Lozano, Maria F Colorado-Zavala, Eugenia M Ramos-Dávila, Manuel E Quiroga-Garza, Nadim S Azar, Hazem M Mousa, Julio C Hernández-Camarena, Sandra S Stinnett, Melissa Daluvoy, Terry Kim, Maite Sainz-de-la-Maza, Russell P Hall, Alejandro Rodriguez-Garcia, Victor L Perez
PURPOSE: Analyze the influence of risk factors at presentation in the long-term immunosuppressive therapy (IMT) outcomes of ocular mucous membrane pemphigoid (OMMP). DESIGN: Retrospective multicenter study. PARTICIPANTS: OMMP patients seen at Duke Eye Center, Tecnologico de Monterrey, and Hospital Clinic of Barcelona from 1990-2022. METHODS: Data at presentation on demographics, direct immunofluorescence and ocular findings, extraocular sites of involvement (EOM) and prior treatments, in patients with a clinical and/or laboratory diagnosis of OMMP, were analyzed with multivariable analysis and Kaplan-Meier plots to identify factors associated with adverse outcomes...
March 5, 2024: Ophthalmology
https://read.qxmd.com/read/38430073/orbital-inflammation-prompted-by-endovascular-mechanical-thrombectomy
#14
JOURNAL ARTICLE
Mattan Arazi, Gal Yaniv, Guy Ben-Simon
No abstract text is available yet for this article.
March 1, 2024: Ophthalmology
https://read.qxmd.com/read/38430072/anterior-segment-oct-image-of-vitreous-hernia
#15
JOURNAL ARTICLE
Ce Shi, Zhe Xu, Wen Xu
No abstract text is available yet for this article.
March 1, 2024: Ophthalmology
https://read.qxmd.com/read/38416081/an-unusual-pigmented-lesion
#16
JOURNAL ARTICLE
Shambhawi Thakur, Lucie Y Guo, Prithvi Mruthyunjaya
No abstract text is available yet for this article.
February 28, 2024: Ophthalmology
https://read.qxmd.com/read/38423216/phase-3-randomized-clinical-trial-of-the-safety-and-efficacy-of-travoprost-intraocular-implant-in-patients-with-open-angle-glaucoma-or-ocular-hypertension
#17
JOURNAL ARTICLE
Steven R Sarkisian, Robert E Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, James H Burden, Long V Doan, Kerry G Stephens, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
PURPOSE: Evaluate the safety and intraocular pressure (IOP)-lowering efficacy of two models of the travoprost intraocular implant (fast-eluting [FE-implant] and slow eluting [SE-implant]) from one of two pivotal trials (GC-010). DESIGN: Phase 3, multicenter, randomized, double-masked, sham-controlled, non-inferiority trial. PARTICIPANTS: Subjects with open-angle glaucoma or ocular hypertension, using 0 to 3 IOP-lowering medications at screening and having an unmedicated baseline mean diurnal IOP (average of 8AM, 10AM and 4PM timepoints) of ≥ 21 mmHg, and an unmedicated baseline IOP of ≤ 36 mmHg at each timepoint in the study eye...
February 27, 2024: Ophthalmology
https://read.qxmd.com/read/38423215/assessment-of-visual-function-with-cotoretigene-toliparvovec-in-x-linked-retinitis-pigmentosa-in-the-randomized-xirius-phase-2-3-study
#18
JOURNAL ARTICLE
Byron L Lam, Mark E Pennesi, Christine N Kay, Sushil Panda, James A Gow, Guolin Zhao, Robert E MacLaren
PURPOSE: Cotoretigene toliparvovec (BIIB112/AAV8-RPGR) is an investigational vector-based gene therapy designed to provide a full-length, codon-optimized, retinitis pigmentosa GTPase regulator (RPGR) protein to individuals with RPGR-associated X-linked retinitis pigmentosa (XLRP). We assessed efficacy and safety of cotoretigene toliparvovec subretinal gene therapy. DESIGN: Part 2 of the XIRIUS trial (NCT03116113) was a Phase 2/3, 12-month, randomized (1:1:1), dose-expansion study...
February 27, 2024: Ophthalmology
https://read.qxmd.com/read/38416083/surgical-management-of-a-neurofibromatosis-type-1-associated-retinal-detachment
#19
JOURNAL ARTICLE
Etienne Boulanger, Georges Caputo, Thibaut Chapron
No abstract text is available yet for this article.
February 27, 2024: Ophthalmology
https://read.qxmd.com/read/38416082/oct-angiography-of-retinal-capillary-hamartoma
#20
JOURNAL ARTICLE
Zhenlong Ran, Jiayue Wang, Jingxue Ma
No abstract text is available yet for this article.
February 27, 2024: Ophthalmology
journal
journal
20208
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.